Wednesday, February 7, 2018

Cellular and Molecular Immunology - Table of Contents alert Volume 15 Issue 2

If you are unable to see the message below, click here to view.
Cellular & Molecular Immunology
Nature Outlook: Cancer immunotherapy 

Drugs that mobilize our immune systems against cancer are dramatically improving care for many people, and research is rapidly moving ahead in the lab and the clinic. 

Access this Outlook free online for more

Produced with support from 
F. Hoffmann-La Roche Ltd  & Medimmune 
Produced with support of a grant from Merck & Co., Inc.

Volume 15, Issue 2 (February 2018)

In this issue
Research Highlights
Research Articles
Letters to the Editor

Also new
Advertisement webcasts 

Springer Nature presents a custom webcast on: Transforming Translational Research: CANscript™ - A Better Predictive Model For Oncology

Date: Tuesday, February 20, 2018 

Register for the webcast and live Q&A session 

Sponsored by: Mitra Biotech 
Sign up for e-alerts Sign up for e-alerts
Recommend to your library
Web feed
Advertisement webcasts

Springer Nature presents a custom webcast on: Multiple Assays of the Anti-Apoptotic BCL-2 Family

Date: Wednesday, February 28, 2018 

Register for the webcast and live Q&A session 

Sponsored by: Millipore Sigma 

Research Highlights


Dietary therapy may be sufficient for type 1 diabetes treatment

Shuoyang Liu and Xin Chen

Cell Mol Immunol 2018 15: 85-87; advance online publication, July 10, 2017; 10.1038/cmi.2017.56

Full Text

Microbiota or short-chain fatty acids: which regulates diabetes?

Chang H Kim

Cell Mol Immunol 2018 15: 88-91; advance online publication, July 17, 2017; 10.1038/cmi.2017.57

Full Text

Gut microbiota metabolites for sweetening type I diabetes

Thamer Aljutaily, Marta Consuegra-Fernández, Fernando Aranda, Francisco Lozano and Eduardo Huarte

Cell Mol Immunol 2018 15: 92-95; advance online publication, July 31, 2017; 10.1038/cmi.2017.65

Full Text

Clonal expansion shapes the human Vδ1T cell receptor repertoire

Serena Meraviglia and Francesco Dieli

Cell Mol Immunol 2018 15: 96-98; advance online publication, July 24, 2017; 10.1038/cmi.2017.66

Full Text

Research Articles


MicroRNA in vivo precipitation identifies miR-151-3p as a computational unpredictable miRNA to target Stat3 and inhibits innate IL-6 production

Xiang Liu, Xiaoping Su, Sheng Xu, Huamin Wang, Dan Han, Jiangxue Li, Mingyan Huang and Xuetao Cao

Cell Mol Immunol 2018 15: 99-110; advance online publication, September 11, 2017; 10.1038/cmi.2017.82

Abstract | Full Text

Poly-gamma-glutamic acid from Bacillus subtilis upregulates pro-inflammatory cytokines while inhibiting NLRP3, NLRC4 and AIM2 inflammasome activation

Huijeong Ahn, Seung Goo Kang, Sung-il Yoon, Pyeung-Hyeun Kim, Doo Kim and Geun-Shik Lee

Cell Mol Immunol 2018 15: 111-119; advance online publication, May 2, 2016; 10.1038/cmi.2016.13

Abstract | Full Text

Toxoplasma gondii GRA15II effector-induced M1 cells ameliorate liver fibrosis in mice infected with Schistosomiasis japonica

Yuanyuan Xie, Huiqin Wen, Ke Yan, Shushu Wang, Xuesong Wang, Jian Chen, Yuanling Li, Yuanhong Xu, Zhengrong Zhong, Jilong Shen and Deyong Chu

Cell Mol Immunol 2018 15: 120-134; advance online publication, May 9, 2016; 10.1038/cmi.2016.21

Abstract | Full Text

HSP70L1-mediated intracellular priming of dendritic cell vaccination induces more potent CTL response against cancer

Shuxun Liu, Lin Yi, Ma Ling, Jinxia Jiang, Lijun Song, Juan Liu and Xuetao Cao

Cell Mol Immunol 2018 15: 135-145; advance online publication, June 27, 2016; 10.1038/cmi.2016.33

Abstract | Full Text

Selection and characterization of the novel anti-human PD-1 FV78 antibody from a targeted epitope mammalian cell-displayed antibody library

Longlong Luo, Shi Wang, Xiaoling Lang, Tingting Zhou, Jing Geng, Xinying Li, Chunxia Qiao, Jiannan Feng, Beifen Shen, Ming Lv and Yan Li

Cell Mol Immunol 2018 15: 146-157; advance online publication, August 8, 2016; 10.1038/cmi.2016.38

Abstract | Full Text

CD5 expression promotes IL-10 production through activation of the MAPK/Erk pathway and upregulation of TRPC1 channels in B lymphocytes

Soizic Garaud, Taher E Taher, Marjolaine Debant, Miguel Burgos, Sarra Melayah, Christian Berthou, Kaushal Parikh, Jacques-Olivier Pers, Damien Luque-Paz, Gilles Chiocchia, Maikel Peppelenbosch, David A Isenberg, Pierre Youinou, Olivier Mignen, Yves Renaudineau and Rizgar A Mageed

Cell Mol Immunol 2018 15: 158-170; advance online publication, August 8, 2016; 10.1038/cmi.2016.42

Abstract | Full Text

uPAR promotes tumor-like biologic behaviors of fibroblast-like synoviocytes through PI3K/Akt signaling pathway in patients with rheumatoid arthritis

Yan Liu, Yun Feng Pan, You-qiu Xue, Lin-kai Fang, Xing-hua Guo, Xin Guo, Meng Liu, Bi-yao Mo, Meng-ru Yang, Fang Liu, Yun-ting Wu, Nancy Olsen and Song Guo Zheng

Cell Mol Immunol 2018 15: 171-181; advance online publication, January 16, 2017; 10.1038/cmi.2016.60

Abstract | Full Text

Letters to the Editor


Multi-epitope vaccines: a promising strategy against tumors and viral infections

Lifang Zhang

Cell Mol Immunol 2018 15: 182-184; advance online publication, September 11, 2017; 10.1038/cmi.2017.92

Full Text

Non-coding RNA: a key regulator of the pathogenicity and immunity of Flaviviridae viruses infection

Zhiyi Zhang, Lifang Jiang and Gucheng Zeng

Cell Mol Immunol 2018 15: 185-186; advance online publication, October 9, 2017; 10.1038/cmi.2017.86

Full Text

Revisiting GM-CSF as an adjuvant for therapeutic vaccines

Weidong Zhao, Gan Zhao and Bin Wang

Cell Mol Immunol 2018 15: 187-189; advance online publication, October 23, 2017; 10.1038/cmi.2017.105

Full Text

Gut-homing α4β7 CD4+ T cells: potential key players in both acute HIV infection and HIV-associated cancers

Yang Wang, Xiaofan Lu, Hao Wu and Wei Li

Cell Mol Immunol 2018 15: 190-192; advance online publication, October 30, 2017; 10.1038/cmi.2017.104

Full Text

Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Cellular & Molecular Immunology. In order to do so, please purchase a subscription.

You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your account at: (You will need to log in to be recognised as a registrant).

For further technical assistance, please contact our registration department.

For print subscription enquiries, please contact our subscription department.

For other enquiries, please contact our customer feedback department.

Springer Nature |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA

Springer Nature's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston

Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW.

© 2018 Macmillan Publishers Limited, part of Springer Nature. All Rights Reserved.

Springer Nature

No comments: